» Newsletter
» Suscribe
» Search NM Extra
» Search Videos
» Contact us
» Archive
» Advanced Search
Username
Password
» Forgot your Password?
Monday, February 6, 2012
Español
FDA Panel Rejects Avastin as Breast Cancer Drug
|
Home
Regulatory
FDA (Extra)
Approvals (FDA, Total)
Not Approved
Complete Response Letters
Positiv Recommend. (Panels)
Negative Recommend. (Panels)
NDA
sNDA
BLA
sBLA
IND
Fast Track
Orphan Drugs
Priority Review
Pediatric Approvals
Appeals
Labels (Updates, Changes)
EMEA (Others)
Approvals (EMEA, Total)
Competence Watchdogs (US and Europe)
Recalls, Alerts and Opinions (FDA-EMEA)
Legals
Patent Challenge (ANDA)
Patent Copy
Court Decisions
Suits
Class Actions
Blocks (Pharma)
Blocks (Biotecnology)
Brands
US. Congress
Pharma
Approvals
Review Extension
Clinical Trials
Pipeline
Forecast (Investments Banks and Analysts)
Drugs in-depht
Express QTR
QTR
Business News (Licences, Deals)
Mergers & Acquisitions
Other News
Biotechnology
Vaccines
Approvals
Not Approved
Review Extension
Clinical Trials
Drugs in-depth
Forecast (Investments Banks and Analysts)
Pipeline
Express QTR
QTR
Business News (Licences, Deals)
Mergers & Acquisitions
Other News
Generics
News
Tentative Approval
Biosimilars
Industry
News
Express Rankings
Rankings
Market Data
CEOs
Trends
Other Business
Other Markets
Opinions
PRNewswire
News
Network Médica
Staff
Contact us
Suscribe
More Information
I wish to receive the free Newsletter
Advanced search
This search tool will allow you to find articles by filling in words included in it.
word/s to search
(remember tildes))
Search by
Exact words
All words
Some words
Search
Since
to
Results by page
5
10
15
20
25
50
100
(day,month,year)
(day,month,year)
Results ordered by date
Ascendant
Descendant
All sections
Regulatory
FDA (Extra)
Not Approved
Positiv Recommend. (Panels)
NDA
BLA
IND
Orphan Drugs
Pediatric Approvals
Labels (Updates, Changes)
Approvals (EMEA, Total)
Recalls, Alerts and Opinions (FDA-EMEA)
Approvals (FDA, Total)
Complete Response Letters
Negative Recommend. (Panels)
sNDA
sBLA
Fast Track
Priority Review
Appeals
EMEA (Others)
Competence Watchdogs (US and Europe)
Legals
Patent Challenge (ANDA)
Court Decisions
Class Actions
Blocks (Biotecnology)
US. Congress
Patent Copy
Suits
Blocks (Pharma)
Brands
Pharma
Approvals
Clinical Trials
Forecast (Investments Banks and Analysts)
Express QTR
Business News (Licences, Deals)
Other News
Review Extension
Pipeline
Drugs in-depht
QTR
Mergers & Acquisitions
Biotechnology
Vaccines
Not Approved
Clinical Trials
Forecast (Investments Banks and Analysts)
Express QTR
Business News (Licences, Deals)
Other News
Approvals
Review Extension
Drugs in-depth
Pipeline
QTR
Mergers & Acquisitions
Generics
News
Biosimilars
Tentative Approval
Industry
News
Rankings
CEOs
Other Business
Opinions
Express Rankings
Market Data
Trends
Other Markets
PRNewswire
News